Creo Medical Limited (CREO.L) LSE
14.13
+0.175(+1.25%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Creo Medical Limited
Address
Unit 2, Creo House
Chepstow, NP16 5UH
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1291 606005
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
278
First IPO Date
December 09, 2016
Key Executives
| Name | Title | Pay | Year Born |
| Craig Jonathan Gulliford | Chief Executive Officer & Executive Director | 377,174 | 1970 |
| Christopher Paul Hancock | Founder & CTO | 260,411 | 1967 |
| Richard John Rees | Chief Financial Officer & Executive Director | 264,633 | 1976 |
| David Gerard Woods | Chief Commercial Officer | 312,916 | 1965 |
| Richard Gary Craven | Secretary | 0 | N/A |
| Phil Hales | Sales & Marketing Director | 0 | N/A |
Description
Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.
